U.S. Markets closed
  • S&P 500

    4,145.19
    -6.75 (-0.16%)
     
  • Dow 30

    32,803.47
    +76.67 (+0.23%)
     
  • Nasdaq

    12,657.55
    -63.04 (-0.50%)
     
  • Russell 2000

    1,921.82
    +15.36 (+0.81%)
     
  • Crude Oil

    88.53
    -0.01 (-0.01%)
     
  • Gold

    1,792.40
    -14.50 (-0.80%)
     
  • Silver

    19.86
    -0.26 (-1.30%)
     
  • EUR/USD

    1.0185
    -0.0065 (-0.6315%)
     
  • 10-Yr Bond

    2.8400
    +0.1640 (+6.13%)
     
  • Vix

    21.15
    -0.29 (-1.35%)
     
  • GBP/USD

    1.2070
    -0.0088 (-0.7266%)
     
  • USD/JPY

    134.9700
    +1.9540 (+1.4690%)
     
  • BTC-USD

    23,207.04
    +19.22 (+0.08%)
     
  • CMC Crypto 200

    533.20
    -2.02 (-0.38%)
     
  • FTSE 100

    7,439.74
    -8.32 (-0.11%)
     
  • Nikkei 225

    28,175.87
    +243.67 (+0.87%)
     

AstraZeneca CFO Sarin on Earnings, Covid, M&A Pipeline

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

AstraZeneca Plc Chief Financial Officer Aradhana Sarin discusses the company's financial results, outlook and strategy. Cambridge, England-based Astra raised its outlook for 2022 revenue after second-quarter sales and earnings per share exceeded analysts' expectations, fueled by growth in all disease areas including Covid-19 medicines. Sarin speaks with Tom Mackenzie on "Bloomberg Markets: Europe."